Boston Advisors’s Stericycle Inc SRCL Stock Holding History

Boston Advisors’s Portfolio SRCL Stock Details SRCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-8,300	Closed	-$594K	–	675
2017 Q3	$594K	Sell	8,300 -300	-3%	-$22.1K	0.01%	453
2017 Q2	$656K	Buy	+8,600	New	+$707K	0.02%	435

Other funds holding SRCL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Fairpointe Capital Chicago, Illinois $66.3M AUM 101.32% 1-Year Est. Return

CCP

Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Boston Advisors's SRCL Position: Q4 2017 in Review

Boston Advisors sold out of Stericycle Inc (SRCL) in Q4 2017, closing a stake of 8,300 shares — an estimated $594K sold.

Boston Advisors first reported a position in SRCL in Q2 2017 and held it in 2 quarters. The position peaked at $656K in Q2 2017. 520 funds tracked by Wall St. Rank hold SRCL as of Q4 2017.

Boston Advisors reported no remaining Stericycle Inc position as of Q4 2017 after selling out during the quarter.
Boston Advisors sold 8,300 Stericycle Inc shares in Q4 2017, an estimated $594K.
Boston Advisors first reported a position in Stericycle Inc in Q2 2017 and held it in 2 quarters.
Boston Advisors's Stericycle Inc position peaked at $656K in Q2 2017.
520 funds tracked by Wall St. Rank held Stericycle Inc as of Q4 2017.

Based on Boston Advisors's 13F filing for Q4 2017, filed 24 Jan 2018.